VANCOUVER, BC - March 3, 2025 - 0913693 B.C. Ltd. (formerly Replicel Life Sciences Inc.) (the "Company") announces that, further to its news release dated February 14, 2025, the Company has completed its change of name from "Replicel Life Sciences Inc." to "0913693 B.C. Ltd." effective today, March 3, 2025 (the "Name Change").
No action is required to be taken by shareholders with respect to the Name Change. Outstanding share and warrant certificates are not affected by the Name Change and do not need to be exchanged. The Company's ISIN and CUSIP numbers for the common shares will change to CA9889361007 and 988936100, respectively.
For more information, please contact:
info@replicel.com
Phone: +1 (604) 248-8730
Cautionary Statement Regarding Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Further, the ongoing labour shortages, high energy costs, inflationary pressures, rising interest rates, the global financial climate and conflicts in Ukraine and Palestine and surrounding regions are some additional factors that are affecting current economic conditions and increasing economic uncertainty, which may impact the operating performance, financial position, and future prospects of the Company. Collectively, the potential impacts of this economic environment pose risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers should also refer to the risk factor disclosure contained in the public filings of the Company filed with Canadian securities regulators and available under the Company's profile on SEDAR+ at www.sedarplus.ca.
No action is required to be taken by shareholders with respect to the Name Change. Outstanding share and warrant certificates are not affected by the Name Change and do not need to be exchanged. The Company's ISIN and CUSIP numbers for the common shares will change to CA9889361007 and 988936100, respectively.
For more information, please contact:
info@replicel.com
Phone: +1 (604) 248-8730
Cautionary Statement Regarding Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Further, the ongoing labour shortages, high energy costs, inflationary pressures, rising interest rates, the global financial climate and conflicts in Ukraine and Palestine and surrounding regions are some additional factors that are affecting current economic conditions and increasing economic uncertainty, which may impact the operating performance, financial position, and future prospects of the Company. Collectively, the potential impacts of this economic environment pose risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Readers should also refer to the risk factor disclosure contained in the public filings of the Company filed with Canadian securities regulators and available under the Company's profile on SEDAR+ at www.sedarplus.ca.
© 2025 PR Newswire
